Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 831-840 of 3376 for cancer

Edit search filters
  1. Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. A Study to Evaluate the Safety of HANAROSTENT® Biliary Flap Lasso Stent System Use to Treat Cancer Patients with Biliary Obstruction

    Rochester, MN

  3. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

    Jacksonville, FL, Rochester, MN

  4. A Study to Evaluate Radiation Therapy, Plasma Exchange, and Immunotherapy in Melanoma

    Rochester, MN

  5. Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/​Refractory T-cell Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ

  6. A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  8. BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants (PATAPSCO)

    Scottsdale/Phoenix, AZ

  9. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

    Jacksonville, FL, Rochester, MN

  10. 3D Ultrasound Imaging for Breast Cancer Diagnosis

    Rochester, MN

.

Mayo Clinic Footer